Josef Walek
Investitore di Private Equity presso MBG Mittelständische Beteiligungs Baden-Württemberg GmbH
Profilo
Dr. Josef Walek is an Investment Manager at MBG Mittelständische Beteiligungs GmbH Baden-Württemberg.
He is on the Board of Directors at CellGenix GmbH.
Dr. Walek was previously employed as an Investment Manager by IKB Invest GmbH and an Investment Manager by IKB Equity Finance GmbH.
Posizioni attive di Josef Walek
Società | Posizione | Inizio |
---|---|---|
MBG Mittelständische Beteiligungs Baden-Württemberg GmbH
MBG Mittelständische Beteiligungs Baden-Württemberg GmbH Investment ManagersFinance MBG Mittelständische Beteiligungs Baden-Württemberg GmbH (MBG Baden-Württemberg) is the private equity and venture capital division of Bürgschaftsbank Baden-Württemberg GmbH. The firm was founded in 1971. It is headquartered in Stuttgart, Germany. | Investitore di Private Equity | 01/01/2013 |
Precedenti posizioni note di Josef Walek
Società | Posizione | Fine |
---|---|---|
IKB Invest GmbH
IKB Invest GmbH Investment ManagersFinance IKB Invest GmbH (IKB-PE) is the private equity arm and a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). The bank's activities include domestic corporate lending, real estate finance, structured finance, private equity, treasury and financial markets. KfW holds a significant minority interest in the IKB group, and both banks have established a strategic partnership. Another significant shareholder is Stiftung Industrieforschung, a foundation established in 1974 following the merger between IKB-Industriekreditbank and Deutsche Industriebank, for the purpose of promoting commercial enterprise. Established in 1987, IKB-PE is headquartered in Dusseldorf, Germany. | Investitore di Private Equity | 28/02/2014 |
IKB Equity Finance GmbH
IKB Equity Finance GmbH Investment ManagersFinance IKB Equity Finance GmbH (IKB-EF) is a wholly-owned subsidiary of IKB Private Equity GmbH which is part of the private equity arm and in turn a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). IKB-EF was established in 2007 when the bank's private equity arm was reorganized. The firm focuses on direct equity investments while IKB Private Equity GmbH specializes in mezzanine financing. | Investitore di Private Equity | 01/04/2010 |
Sartorius CellGenix GmbH
Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
IKB Equity Finance GmbH
IKB Equity Finance GmbH Investment ManagersFinance IKB Equity Finance GmbH (IKB-EF) is a wholly-owned subsidiary of IKB Private Equity GmbH which is part of the private equity arm and in turn a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). IKB-EF was established in 2007 when the bank's private equity arm was reorganized. The firm focuses on direct equity investments while IKB Private Equity GmbH specializes in mezzanine financing. | Finance |
IKB Invest GmbH
IKB Invest GmbH Investment ManagersFinance IKB Invest GmbH (IKB-PE) is the private equity arm and a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). The bank's activities include domestic corporate lending, real estate finance, structured finance, private equity, treasury and financial markets. KfW holds a significant minority interest in the IKB group, and both banks have established a strategic partnership. Another significant shareholder is Stiftung Industrieforschung, a foundation established in 1974 following the merger between IKB-Industriekreditbank and Deutsche Industriebank, for the purpose of promoting commercial enterprise. Established in 1987, IKB-PE is headquartered in Dusseldorf, Germany. | Finance |
Sartorius CellGenix GmbH
Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Health Technology |
MBG Mittelständische Beteiligungs Baden-Württemberg GmbH
MBG Mittelständische Beteiligungs Baden-Württemberg GmbH Investment ManagersFinance MBG Mittelständische Beteiligungs Baden-Württemberg GmbH (MBG Baden-Württemberg) is the private equity and venture capital division of Bürgschaftsbank Baden-Württemberg GmbH. The firm was founded in 1971. It is headquartered in Stuttgart, Germany. | Finance |
- Borsa valori
- Insiders
- Josef Walek